NanoView Biosciences

Biotechnology ResearchMassachusetts, United States11-50 Employees

NanoView Biosciences is a biotechnology research firm focused on advancing precision medicine through tools that support research, translation, and delivery of targeted therapies. The company develops proprietary methods to identify and characterize exosomes, enabling researchers to study cellular communication and its role in disease. In 2021, it launched ExoView R200 to enable sensitive detection and characterization of extracellular vesicles. Its customers are life science researchers seeking to understand cellular communication and its implications for diagnosing, treating, and monitoring disease. Based in Boston, Massachusetts, NanoView operates as a small to mid-sized firm, and in May 2022 it was acquired by Unchained Labs.

Sign up for free to view info

Email Format Employee directory